CADL CIK: 1841387

Candel Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−22.2
FY22:
−31.4
FY23:
−34.2
FY24:
−27.0
FY25:
−38.3
Change from FY21 to FY25
millions USD
FY21:
−1.84
FY22:
−1.30
FY23:
−0.28
FY24:
−0.02
FY25:
−0.56
Change from FY21 to FY25
millions USD
FY21:
71.8
FY22:
20.0
FY23:
−0.12
FY24:
94.3
FY25:
56.1
millions USD
FY21:
47.7
FY22:
−12.7
FY23:
−34.6
FY24:
67.2
FY25:
17.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.1
FY22:
−32.7
FY23:
−34.7
FY24:
−27.0
FY25:
−38.9

All amounts in millions USD Data source:SEC EDGAR